A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

Clinical trial NCT04264806 · WITHDRAWN

Trial details

NCT number: NCT04264806
Sponsor: Janssen Research & Development, LLC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Leukemia, Myelomonocytic, Chronic

Start date: 2021-05-06
Primary completion: 2022-04-19
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.